Abstract:Background: Numerous studies have examined the therapeutic effects of mitral valve repair during revascularization on moderate ischemic mitral regurgitation (IMR), as well as the incremental benefit of subvalvular repair alongside an annuloplasty ring. However, the impact of depressed left ventricular (LV) function on the surgical outcome of patients with moderate IMR has been rarely investigated. The aims of this single-center, retrospective, observational study were firstly to evaluate short- and medium-term outcomes in this patient group after undergoing mitral valve repair during revascularization, and secondly to assess the impact of depressed LV function on surgical outcomes. Methods: A total of 272 eligible patients who had moderate IMR and underwent concomitant mitral valve repair and revascularization from January 2010 to December 2017 were included in the study. These patients were categorized into different groups based on their ejection fraction (EF) levels: an EF <40% group (n = 90) and an EF ≥40% group (n = 182). The median time course of follow-up was 42 months and the shortest follow-up time was 30 months. This study compared in-hospital outcomes (major postoperative morbidity and surgical mortality) as well as midterm outcomes (moderate or more mitral regurgitation, all-cause mortality, and reoperation) of the two groups before and after propensity score (PS) matching (1:1). Results: No significant difference was observed in surgical mortality between groups (8.9% vs. 3.3%, p = 0.076). More patients in the EF <40% group developed low cardiac output (8.9% vs. 2.7%, p = 0.034) and prolonged ventilation (13.3% vs. 5.5%, p = 0.026) compared to the EF ≥40% group. Propensity score (PS) matching successfully established 82 patient pairs in a 1:1 ratio. No significance was discovered between the matched cohorts in terms of major postoperative morbidity and surgical mortality, except for prolonged ventilation. Conditional mixed-effects logistic regression analysis revealed that EF <40% had an independent impact on prolonged ventilation (odds ratio (OR) = 2.814, 95% CI 1.321–6.151, p = 0.031), but was not an independent risk factor for surgical mortality (OR = 2.967, 95% CI 0.712–7.245, p = 0.138) or other major postoperative morbidity. Furthermore, the two groups showed similar cumulative survival before (log-rank p = 0.278) and after (stratified log-rank p = 0.832) PS matching. Cox regression analysis suggested that EF <40% was not related to mortality compared with EF ≥40% (PS-adjusted hazard ratio (HR) = 1.151, 95% CI 0.763–1.952, p = 0.281). Conclusions: Patients with moderate IMR and EF <40% shared similar midterm outcomes and surgical mortality to patients with moderate IMR and EF ≥40%, but received prolonged ventilation more often. Depressed LV function may be not associated with surgical or midterm mortality.

Myectomy with and without Mitral Subvalvular Repair in Patients with Hypertrophic Obstructive Cardiomyopathy with Grade 3 to 4+Mitral Regurgitation without Intrinsic Mitral Valve Disease: A Retrospective Observational Study

Characteristics And Surgical Results Of Patients With Hypertrophic Obstructive Cardiomyopathy Without Intrinsic Mitral Valve Diseases Undergoing Mitral Subvalvular Procedures During Myectomy

Influence of percutaneous transluminal septal myocardial ablation of hypertrophic obstructive cardiomyopathy on mitral regurgitation

Selective Interventricular Septal Radiofrequency Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?

Combined mitral valve replacement and partial septal myectomy in patients with hypertrophic obstructive cardiomyopathy and mitral regurgitation

Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy: Acute Results and Three-Year Noninvasive Follow-Up in 18 Patients.

Application of special surgical instruments in transaortic septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy

Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results

Echocardiographic and Clinical Outcomes of Concomitant Secondary Chordal Cutting to Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-analysis

Hypertrophic obstructive cardiomyopathy with a basal septal thickness of 16 mm or less: clinical characteristics and surgical results

Septuagenarians with Hypertrophic Obstructive Cardiomyopathy Undergoing Myectomy: the Experience of a Single Center

Extended septal myectomy for obstructive hypertrophic cardiomyopathy and its impact on mitral valve function

Mini-invasive Surgical Instruments in Transaortic Myectomy for Hypertrophic Obstructive Cardiomyopathy: a Single-Center Experience with 168 Cases

Enlargement of Left Ventricular Outflow Tract Using an Autologous Pericardial Patch for the Anterior Mitral Valve Leaflet and Septal Myectomy Through Trans-mitral Approach for the Treatment of Hypertrophic Obstructive Cardiomyopathy

Surgical outcome of mitral valve surgery in atrial functional mitral regurgitation compared with degenerative etiology

Mitral Valve Repair and Surgical Ablation for Atrial Functional Mitral Regurgitation

Reverse remodeling of left atrium assessed by cardiovascular magnetic resonance feature tracking in hypertrophic obstructive cardiomyopathy after septal myectomy

Hypertrophic cardiomyopathy with latent obstruction: Clinical characteristics and surgical results

A three-year follow-up comparative study for treating hypertrophic obstructive cardiomyopathy with percutaneous transluminal septal myocardial ablation or septal myectomy

Systolic anterior motion-mediated mitral regurgitation and surgical management in hypertrophic obstructive cardiomyopathy

Moderate Ischemic Mitral Regurgitation with Ejection Fraction <40% Undergoing Concomitant Mitral Valve Repair During Revascularization: A Single-Center Observational Study